Article Text

Download PDFPDF
CASE REPORT
Suppression of respiratory papillomatosis with malignant transformation by erlotinib in a kidney transplant recipient
  1. Zhonglin Hao1,
  2. Thomas Dillard2,
  3. Paul Biddinger3,
  4. Vijay Patel4
  1. 1Cancer Center, Georgia Regents University, Augusta, Georgia, USA
  2. 2Department of Pulmonary Medicine, Georgia Regents University, Augusta, Georgia, USA
  3. 3Department of Pathology, Georgia Regents University, Augusta, Georgia, USA
  4. 4Department of Cardiothoracic Surgery, Georgia Regents University, Augusta, Georgia, USA
  1. Correspondence to Dr Zhonglin Hao, zhao{at}gru.edu; zhonglin_hao{at}yahoo.com

Summary

A 52-year-old non-smoker and renal transplant recipient developed an incessant cough. A CT scan of the thorax revealed ill-defined hazy opacities in the right upper lung. He was diagnosed with non-tuberculosis Mycobacterium chelonae/abscessus infection based on sputum culture results. A trial of antibiotics initially resulted in some clinical improvement. A subsequent CT of the thorax documented worsening of the lesions in the right lung and new lesions on the left. An intratracheal growth was noted. Bronchoscopy with biopsy of the tracheal lesions documented respiratory papillomatosis with transformation to squamous cell cancer. Test for high-risk human papilloma virus was positive. Video-assisted thoracoscopic surgery biopsy with wedge resection of the left lower lobe revealed metastatic squamous cell lung cancer. He was treated with one ablation followed by four cycles of chemotherapy. He has been maintained on erlotinib ever since. There has been no recurrence of the cough or papillomas.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.